tiprankstipranks
Trending News
More News >

Zynex Faces Continued Payment Suspension from Tricare

Story Highlights
  • Zynex, Inc. specializes in non-invasive medical devices for pain management and monitoring.
  • Tricare continues its payment suspension to Zynex, affecting the company’s operations.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Zynex Faces Continued Payment Suspension from Tricare

Don’t Miss TipRanks’ Half-Year Sale

An update from Zynex ( (ZYXI) ) is now available.

On July 2, 2025, Zynex, Inc. announced that Tricare, its largest insurance customer, will continue the temporary suspension of payments. Despite Zynex’s appeal and presentation of evidence to lift the suspension, Tricare has decided to maintain the suspension while conducting further review, impacting Zynex’s operations and financial stability.

The most recent analyst rating on (ZYXI) stock is a Buy with a $16.00 price target. To see the full list of analyst forecasts on Zynex stock, see the ZYXI Stock Forecast page.

Spark’s Take on ZYXI Stock

According to Spark, TipRanks’ AI Analyst, ZYXI is a Neutral.

Zynex’s overall stock score is heavily impacted by its financial difficulties, which are the most significant factor. Despite some technical and strategic positives, the company’s financial health and valuation concerns dominate, requiring critical focus on revenue growth and cost management for improvement.

To see Spark’s full report on ZYXI stock, click here.

More about Zynex

Zynex, Inc., founded in 1996, is a medical technology company that develops, manufactures, and sells non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The company focuses on providing innovative solutions for hospitals, including fluid, sepsis, and laser-based pulse oximetry monitoring systems.

Average Trading Volume: 235,677

Technical Sentiment Signal: Sell

Current Market Cap: $80.44M

See more data about ZYXI stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1